NVSEF News and Press, Novartis Ag Basel Akt From 06/11/20

This article is part of a series that provides an ongoing analysis of the changes made to Tweedy, Browne's 13F portfolio on a quarterly basis. It is based on Tweedy, Browne's regulatory 13F Form filed on 05/13/2020. Please visit our Tracking Tweedy, Browne Portfolio series to get an idea o...

FSD Pharma Stock Jumps on FDA Nod for COVID 19 Trial FSD Pharma Inc. ( HUGE ) announced that the FDA has provided its approval to the company for the design of its COVID-19 trial. The approval now allows the company to submit an Investigational New Drug Application for using its drug can...

Quick Take Avidity Biosciences ( RNA ) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The firm is developing treatments for diseases including various dystrophies and Pompe disease. RNA is a very early stage firm but has a sig...

Quick Take Legend Biotech ( LEGN ) intends to raise $350 million in an IPO of its ADSs representing ordinary shares, per an amended registration statement . The company is advancing a pipeline of treatments for diseases of the blood and for solid tumors. LEGN has produced impressive res...

Quick Take Pliant Therapeutics ( PLRX ) intends to raise $90 million from the sale of its common stock in an IPO, plus another $10 million in a concurrent private placement, according to an amended registration statement . The company is developing treatments for fibrosis, cancer and othe...

This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn’s Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking David Einhorn's Greenlig...

On April 8, 2020, within the body of my T he Best COVID-19 Stock No One Knows About It: United Natural Foods (UNFI) article, I wrote the following: As of January 2020, COVID-19 has dramatically changed the world. Life as we know it will be different, and profoundly so, most likely in ...

Quick Take Legend Biotech Corp. ( LEGN ) has filed to raise $100 million in an IPO of its ADSs representing ordinary shares, according to an F-1 registration statement . Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for mult...

Quick Take Calliditas Therapeutics AB ( CALT ) has filed to raise $75 million in an IPO of its ADSs representing common shares, according to an F-1 registration statement. The company is developing drug treatments for renal and hepatic disease conditions. CALT has produced promising Ph...

Pharma is well-known as an extremely high margin business, capable of generating substantial incremental shareholder value due to its capacity to leverage the economics of patents and its relatively low incremental investment rates. Indeed, the profitability of Pharma has made it a political t...